Patent Assignment
Reel/Frame 038870/0160
Assignment of Assignor's Interest
Recorded: 2016-06-03
Pages: 28
Assignor
BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Executed: 2016-06-02
Assignee
REVANCE THERAPEUTICS, INC.
7555 GATEWAY BOULEVARD, NEWARK, CALIFORNIA, 94560
Covered Properties
(58)
Methods of Using Botulinum Toxin for the Treatment of Hypervolemic Lip Deformity (Lip Ectropion)
PCT:
PCT/US2005/000117 ↗
Compositions, Methods and Devices for Preparing Less Painful Botulinum Toxin Formulations
PCT:
PCT/US2005/002685 ↗
High-Potency Botulinum Toxin Formulations
PCT:
PCT/US2006/015459 ↗
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
PCT:
PCT/US2006/022157 ↗
Controlled Administration of Chemodenervating Pharmaceuticals
Patent:
5,183,462 →
Application:
07/570,395 →
Controlled Administration of Chemodenervating Pharmaceuticals
Patent:
5,298,019 →
Application:
08/004,090 →
Controlled Administration of Chemodenervating Pharmaceuticals
Patent:
5,401,243 →
Application:
08/046,097 →
Pharmaceutical Composition Containing Botulinum B Complex
Application:
08/140,328 →
Pharmaceutical Composition Containing Botulinum B Complex
Patent:
5,696,077 →
Application:
08/316,820 →
Chemodenervating Pharmaceutical as Anti-Inflammatory Agent
Patent:
7,537,773 →
Application:
09/382,837 →
Cytotoxin (Non-Neurotoxin) for the Treatment of Human Headache Disorders and Inflammatory Diseases
Patent:
6,429,189 →
Application:
09/458,784 →
Use of botulinum toxin for the treatment of chronic facial pain
Application:
10/040,830 →
Publication:
US 2002/0192239
Cytotoxin (non-neurotoxin) for the treatment of human headache disorders and inflammatory diseases
Application:
10/212,657 →
Publication:
US 2002/0187164
Composition for Therapeutic and Cosmetic Botulinum Toxin
Pharmaceutical Botulinum Toxin Compositions
Treatment of Chronic Chalazion and Hordeolum with Botulinum Toxin
Selection of Patients with Increased Responsiveness to Botulinum Toxin
Treatment of sinusitis related chronic facial pain and headache with botulinum toxin injections
Methods of Using Botulinum Toxin for the Treatment of Hypervolemic Lip Deformity (Lip Ectropion)
Compositions, Methods and Devices for Preparing Less Painful Botulinum Toxin Formulations
High-Potency Botulinum Toxin Formulations
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
Use of botulinum toxin for the treatment of chronic facial pain
Application:
11/505,356 →
Publication:
US 2010/0278867
Composition for therapeutic and cosmetic botulinum toxin
Treatment of Chronic Chalazion and Hordeolum with Botulinum Toxin
Pharmaceutical Botulinum Toxin Compositions
Albumin-Free Botulinum Toxin Based Pharmaceutical Compositions Containing a Hyaluronidase and Methods of Use
Application:
12/083,058 →
Publication:
US 2009/0324647
Anti-Inflammatory Topical Botulinum Toxin Composition
Application:
12/318,572 →
Publication:
US 2009/0148476
High-Potency Botulinum Toxin Formulations
Extended Length Botulinum Toxin Formulation for Human or Mammalian Use
Use of Botulinum Toxin for the Treatment of Cerebrovascular Disease, Renovascular and Retinovascular Circulatory Beds
High-Potency Botulinum Toxin Formulations
Application:
14/225,011 →
Publication:
US 2014/0315820
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
Application:
14/464,740 →
Publication:
US 2016/0051643
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
Application:
14/552,755 →
Publication:
US 2015/0086532
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
Application:
14/555,870 →
Publication:
US 2015/0086533
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
Application:
14/573,659 →
Publication:
US 2015/0132283
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
Application:
14/722,990 →
Publication:
US 2015/0258183
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
Application:
14/753,917 →
Publication:
US 2015/0297688
Extended Length Botulinum Toxin Formulation for Human or Mammalian Use
Topical Ocular Preparation of Botulinum Toxin for Use in Ocular Surface Disease
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
Use of Botulinum Toxin for the Treatment of Cerebrovascular Disease, Renovascular and Retinovascular Circulatory Beds
Botulinum Toxin for Primary Disorders of Mood and Affect using Neurotransmitter CNS imaging Studies
Application:
14/966,759 →
Publication:
US 2016/0095908
Use of botulinum toxin for the treatment of chronic facial pain
Application:
60/260,515 →
New composition of the therapeutic and cosmetic botulinum toxin
Application:
60/383,570 →
Enhanced sequestration (molecular anchor) of therapeutic botulinum using increased amounts of albumin excipient
Application:
60/435,901 →
Treatment of chronic chalazion and hordeolum with botulinum toxin injections
Application:
60/453,029 →
Treatment of sinusitis related chronic facial pain and headache with botulinum toxin injections
Application:
60/453,037 →
Use of Botulinum toxin for the treatment of hypervolemic lip deformity (lip ectropion)
Application:
60/534,330 →
Compositions and methods of preparing less painful liquid botulinum toxin formulations
Application:
60/640,231 →
Botulinum toxin and the treatment of depressive, anxiety and sleep disorders
Application:
60/690,162 →
Botulinum toxin and the treatment of primary disorders of mood and effect
Application:
60/693,771 →
Botulinum toxin and the treatment of depressive, anxiety and sleep disorders
Application:
60/721,060 →
Botulinum toxin based pharmaceutical compositions
Application:
60/724,913 →
Botulinum toxin and the treatment of primary disorders of mood and affect
Application:
60/738,981 →
Extended length botulinum toxin formulation for human or mammalian use
Application:
61/193,513 →
Use of Botulinum Toxin for the Treatment of Cerebrovascular Disease, renovascular and retinovascular circulatory beds
Application:
61/623,087 →
Topical Ocular Preparation of Botulinum Toxin for Use in Ocular Surface Disease
Application:
62/026,093 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest.
Nov 12, 1991
From: BORODIC, GARY E.; PEARCE, BRUCE
To: PITCHER, EDMOND
Reel/Frame 005906/0177 →
Assignment of Assignors Interest.
Feb 7, 1992
From: BORODIC, GARY E.
To: SYNAPSE BIOLOGICS, INC.
Reel/Frame 006008/0422 →
Assignment of Assignors Interest.
Feb 7, 1992
From: SYNAPSE BIOLOGICS, INC.
To: ASSOCIATED SYNAPSE BIOLOGICS
Reel/Frame 006008/0412 →
Assignment of Assignors Interest.
Feb 7, 1992
From: PITCHER, EDMUND R.
To: SYNAPSE BIOLOGICS, INC.
Reel/Frame 006008/0417 →
Assignment of Assignors Interest.
Apr 12, 1993
From: BORODIC, GARY E.
To: ASSOCIATED SYNAPSE BIOLOGICS
Reel/Frame 006529/0330 →
Assignment of Assignor's Interest
Aug 11, 1995
From: ASSOCIATED SYNAPSE BIOLOGICS
To: INTERACTIVE BIOLOGICS ASSOCIATES
Reel/Frame 007570/0331 →
Assignment of Assignor's Interest
Aug 14, 1995
From: ASSOCIATED SYNAPSE BIOLOGICS
To: INTERACTIVE BIOLOGICS ASSOCIATES
Reel/Frame 007613/0232 →
Assignment of Assignor's Interest
Feb 7, 2000
From: ASSOCIATED SYNPSE BIOLOGICS
To: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Reel/Frame 010579/0809 →
Assignment of Assignor's Interest
Feb 7, 2000
From: INTERACTIVE BIOLOGICS ASSOCIATES
To: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Reel/Frame 010579/0813 →
Assignment of Assignor's Interest
Apr 15, 2002
From: BORODIC, GARY E.; ACQUADRO, MARTIN A.
To: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Reel/Frame 012815/0131 →
Assignment of Assignor's Interest
Sep 24, 2002
From: BORODIC, GARY E.
To: BOTULINUM TOXIN RESEARCH ASSOCIATES
Reel/Frame 013315/0777 →
Assignment of Assignor's Interest
Apr 6, 2004
From: BORODIC, GARY E.
To: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Reel/Frame 015182/0446 →
Assignment of Assignor's Interest
Apr 6, 2004
From: BORODIC, GARY E.; ACQUADRO, MARTIN
To: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Reel/Frame 015182/0270 →
Assignment of Assignor's Interest
Apr 19, 2004
From: BORODIC, GARY E.
To: BOTULIUM TOXIN RESEARCH ASSOCIATES, INC.
Reel/Frame 015231/0048 →
Assignment of Assignor's Interest
Jun 29, 2004
From: BORODIC, GARY E.
To: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Reel/Frame 014818/0777 →
Assignment of Assignor's Interest
Jun 29, 2004
From: BORODIC, GARY E.; ACQUADRO, MARTIN ANDREW
To: BOTULINUM TOXIN RESEARCH ASSOCATES, INC.
Reel/Frame 014798/0944 →
Assignment of Assignor's Interest
Aug 18, 2004
From: BORODIC, GARY E.; ACQUADRO, MARTIN
To: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Reel/Frame 015816/0422 →
Assignment of Assignor's Interest
Feb 9, 2006
From: BORODIC, GARY E.; ACQUADRO, MARTIN A.
To: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Reel/Frame 017553/0418 →
Assignment of Assignor's Interest
Nov 12, 2008
From: BORODIC, GARY E.; ACQUADRO, MARTIN A.
To: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Reel/Frame 021827/0721 →
Assignment of Assignor's Interest
Mar 20, 2009
From: BORODIC, GARY E.
To: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Reel/Frame 022432/0480 →
Assignment of Assignor's Interest
Jan 12, 2010
From: BORODIC, GARY E.
To: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Reel/Frame 023764/0800 →
Assignment of Assignor's Interest
Jan 29, 2010
From: BORODIC, GARY E.
To: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Reel/Frame 023875/0904 →
Assignment of Assignor's Interest
Mar 24, 2016
From: BORODIC, GARY E, DR
To: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Reel/Frame 038249/0590 →
Corrective Assignment to Correct the Botulinum Toxin Research Associates Should Be Botulinum Toxin Research, Inc. Previously Recorded on Reel 013315 Frame 0777. Assignor(S) Hereby Confirms the Assignment.
Oct 3, 2019
From: BORODIC, GARY E.
To: BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Reel/Frame 050629/0404 →
Security Interest
Mar 18, 2022
From: REVANCE THERAPEUTICS, INC.
To: ATHYRIUM BUFFALO LP
Reel/Frame 059437/0654 →